When a competitor holds a patent that is blocking your product, your business, or your freedom to operate, knowing your legal options is everything. Two of the most powerful tools available at the USPTO are Post-Grant Review (PGR) and Inter Partes Review (IPR). Both are designed to challenge the validity of an issued patent, but they work differently, apply in different timeframes, and carry different strategic weight. Understanding post-grant review vs IPR invalidity is not just a legal exercise. It is a business decision that can make or break your position in a market.
This article is written to help business owners, in-house counsel, startups, and inventors understand both routes in plain language, so you can make smarter decisions without drowning in legal jargon.
Inter Partes Review, commonly known as IPR, is a trial proceeding conducted by the Patent Trial and Appeal Board (PTAB) at the USPTO. It was introduced under the America Invents Act (AIA) in 2012 and quickly became the most widely used patent invalidity challenge mechanism in the United States.
In an IPR, a petitioner challenges the validity of an issued patent based only on prior art, meaning previously published patents or printed publications. The standard for getting an IPR instituted is whether there is a “reasonable likelihood” that at least one challenged claim is unpatentable. Once instituted, the PTAB conducts a full trial-like proceeding and issues a final written decision within 12 months.
IPR is especially popular because it is faster and cheaper than district court litigation, and the success rate for petitioners has historically been significant. When evaluating post-grant review vs IPR invalidity, IPR is often the first route practitioners reach for, simply because of its broad availability and focused scope.
Post-Grant Review is another PTAB proceeding, but it is broader in scope and more powerful in many ways. Unlike IPR, PGR allows challenges based on any ground of invalidity, including prior art, lack of written description, enablement issues, indefiniteness, and subject matter eligibility under Section 101.
However, PGR has a strict timing requirement. A petition for PGR must be filed within nine months of the patent’s grant or reissuance date. Miss that window, and PGR is no longer available to you. This makes PGR a time-sensitive but potent weapon, particularly for patents that are broadly drafted or have fundamental eligibility problems that go beyond just prior art.
The threshold for institution in PGR is also slightly different. The petitioner must show that it is “more likely than not” that at least one claim is unpatentable, which is a higher bar than IPR’s “reasonable likelihood” standard.
Understanding the side-by-side comparison is essential when choosing your route. Here are the most important distinctions:
If the nine-month PGR window has already passed, IPR is your primary PTAB option. But even within the PGR window, IPR can sometimes be the smarter choice.
Choose IPR when your strongest invalidity arguments are rooted in prior art. If you have a compelling prior art reference or combination that clearly anticipates or renders obvious the challenged claims, IPR is well-suited. It has a more developed body of PTAB precedent, experienced judges are familiar with its procedures, and the “reasonable likelihood” threshold is easier to meet.
IPR is also preferred when you want to minimize estoppel risk. Since IPR grounds are narrower, you preserve more invalidity arguments for district court litigation if the IPR does not fully resolve the dispute.
PGR is a powerful option when the patent in question has more fundamental problems beyond just prior art. If you believe the claims are directed to abstract ideas or natural phenomena under Section 101, or if the specification fails to adequately support the claims under Section 112, PGR is the only PTAB route that lets you raise those arguments.
Consider PGR when:
The broader scope of PGR can be particularly valuable against software patents, business method patents, and biotech claims where eligibility and written description issues are common.
Before committing to either route in a post-grant review vs IPR invalidity dispute, consider these strategic points:
The debate around post-grant review vs IPR invalidity is not about which proceeding is universally better. It is about which one fits your specific facts, timeline, and litigation goals. IPR offers a focused, widely available, and procedurally mature pathway. PGR offers broader grounds but demands speed and carries heavier estoppel consequences.
For most petitioners, the decision comes down to timing and the nature of the invalidity arguments. If you are within the nine-month window and have grounds beyond prior art, PGR deserves serious consideration. If prior art is your strongest weapon and flexibility matters, IPR is likely your best path.
Either way, engaging an experienced patent litigator early in the process is not optional. The strategic choices made in the first few months after a patent issues, or after a threat letter arrives, often determine the outcome of the entire dispute. Knowing your options in the post-grant review vs IPR invalidity landscape is where that strategy begins.
Effectual Services is an award-winning Intellectual Property (IP) management advisory & Consulting firm.